You are here
Clinical Trials: Cord Blood
Conditions: Sickle Cell Disease; Umbilical Cord Blood; Hematopoietic Cell Proliferation
Intervention: Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors: ExCellThera inc.; California Institute for Regenerative Medicine (CIRM)
Not yet recruiting
Intervention: Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors: ExCellThera inc.; California Institute for Regenerative Medicine (CIRM)
Not yet recruiting
Conditions: COVID-19 Infection; COVID-19-Associated Acute Respiratory Distress Syndrome
Interventions: Other: Best Practice; Biological: Mesenchymal Stem Cell
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
Interventions: Other: Best Practice; Biological: Mesenchymal Stem Cell
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts-2; Myeloid Neoplasm
Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation; Drug: Liposome-encapsulated Daunorubicin-Cytarabine
Sponsors: Fred Hutchinson Cancer Research Center; Jazz Pharmaceuticals
Not yet recruiting
Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation; Drug: Liposome-encapsulated Daunorubicin-Cytarabine
Sponsors: Fred Hutchinson Cancer Research Center; Jazz Pharmaceuticals
Not yet recruiting
Condition: Primary Biliary Cirrhosis
Intervention: Biological: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation
Sponsors: Vinmec Research Institute of Stem Cell and Gene Technology; Children's Hospital Number 2, Ho Chi Minh City, Vietnam
Not yet recruiting
Intervention: Biological: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation
Sponsors: Vinmec Research Institute of Stem Cell and Gene Technology; Children's Hospital Number 2, Ho Chi Minh City, Vietnam
Not yet recruiting
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Human Umbilical Cord Blood-derived Mesenchymal Stem Cells
Sponsors: Gangnam Severance Hospital; Daewoong Pharmaceutical Co. LTD.
Completed
Intervention: Drug: Human Umbilical Cord Blood-derived Mesenchymal Stem Cells
Sponsors: Gangnam Severance Hospital; Daewoong Pharmaceutical Co. LTD.
Completed
Condition: BPD
Interventions: Biological: autologous cord blood mononuclear cells; Biological: normal saline
Sponsors: Guangdong Women and Children Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern Medical University; Zhongshan Boai Hospital; Foshan Chancheng Central Hospital; Foshan Women and Children Hospital; Guangdong Second Provincial General Hospital; Hexian Memorial Affiliated Hospital of Southern Medical University; Heyuan Women and Children Hospital; Jiangmen Women and Children Hospital; Dongguan Women and Children Hospital; Guangzhou Huadu Women and Children Hospital; The fifth Affiliated Hospital of Guangzhou Medcial University; Guang Dong Cord Blood and Stem Cell Bank, Guangzhou , China
Not yet recruiting
Interventions: Biological: autologous cord blood mononuclear cells; Biological: normal saline
Sponsors: Guangdong Women and Children Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern Medical University; Zhongshan Boai Hospital; Foshan Chancheng Central Hospital; Foshan Women and Children Hospital; Guangdong Second Provincial General Hospital; Hexian Memorial Affiliated Hospital of Southern Medical University; Heyuan Women and Children Hospital; Jiangmen Women and Children Hospital; Dongguan Women and Children Hospital; Guangzhou Huadu Women and Children Hospital; The fifth Affiliated Hospital of Guangzhou Medcial University; Guang Dong Cord Blood and Stem Cell Bank, Guangzhou , China
Not yet recruiting
Condition: Virus
Intervention: Combination Product: stem cells
Sponsor: Aljazeera Hospital
Not yet recruiting
Intervention: Combination Product: stem cells
Sponsor: Aljazeera Hospital
Not yet recruiting
Condition: Knee Osteoarthritis
Interventions: Biological: SMUP-IA-01(low-dose); Biological: SMUP-IA-01(mid-dose); Biological: SMUP-IA-01(high-dose)
Sponsor: Medipost Co Ltd.
Not yet recruiting
Interventions: Biological: SMUP-IA-01(low-dose); Biological: SMUP-IA-01(mid-dose); Biological: SMUP-IA-01(high-dose)
Sponsor: Medipost Co Ltd.
Not yet recruiting
Condition: Spinal Cord Contusion
Intervention: Biological: Human Allogeneic Umbilical Cord Blood Mononuclear Cells (hUCBMCs) systemic (i.v.) infusions
Sponsors: Sklifosovsky Institute of Emergency Care; National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Completed
Intervention: Biological: Human Allogeneic Umbilical Cord Blood Mononuclear Cells (hUCBMCs) systemic (i.v.) infusions
Sponsors: Sklifosovsky Institute of Emergency Care; National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Completed
Condition: Chondral or Osteochondral Lesion of Talus
Interventions: Biological: CARTISTEM®; Procedure: Microfracture
Sponsors: SK bioland co., ltd.; Medipost Co Ltd.
Enrolling by invitation
Interventions: Biological: CARTISTEM®; Procedure: Microfracture
Sponsors: SK bioland co., ltd.; Medipost Co Ltd.
Enrolling by invitation
